1. PareP, FerrazziS, ThompsonD, et al.An epidemiological survey of constipation in Canada: definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol2001;96:3130. CrossRef

2. StewartWF, LibermanG, SandlerRS, et al.A large US national epidemiological study of constipation. Gastroenterology1998;114:A44. CrossRef

3. PareP, FerrazziS, ThompsonWG. A longitudinal survey of selfreported bowel habits in the United States. Dig Dis Sci1989;34:1153. CrossRef

4. TalleyNJ, FlemingKC, EvansJM, et al.Constipation in an elderly community: a study of prevelance and potential risk factors. Am J Gastroenterol1996;91:19.

5. LemboA, CamilleriM. Chronic constipation. N Engl J Med2003;349:1360. CrossRef

6. RaoSS. Constipation: evaluation and treatment. Gastroenterol Clin North Am2003;32:659. CrossRef

7. HerzMJ, KahanE, ZalevskiS, et al.Constipation: a different entity for patients and doctors. Fam Pract1996;13:156. CrossRef

8. HigginsPD, JohansonJF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol2004;99:750. CrossRef

9. RaoSS, TutejaAK, VellemaT, et al.Dyssynergic defecation: demographics, symptoms, stool patterns, and quality of life. J Clin Gastroenterol2004;38:680. CrossRef

10. SandlerRS, DrossmanDA. Bowel habits in young adults not seeking healthcare. Dig Dis Sci1987;32:841. CrossRef

11. AshrafW, ParkF, QuigleyEMM, et al.An examination of the reliability of reported stool frequency in the diagnosis of idiopathic constipation. Am J Gastroenterol1996;91:26.

12. RaoSS. Dyssynergic defecation. Gastroenterol Clin North Am2001;30:97. CrossRef

13. ThompsonWG, LongstrethGF, DrossmanDA, et al.Functional bowel disorders and functional abdominal pain. Gut1999;45:1143.

14. DiamantND, KammMA, WaldA, et al.AGA technical review on anorectal testing techniques. Gastroenterology1999;116:735. CrossRef

15. BharuchaAE, WaldA, EnckP, et al.Functional anorectal disorders. Gastroenterology2006;130:1510. CrossRef

16. LongstrethGF, ThompsonWG, CheyWD, et al.Functional bowel disorders. Gastroenterology2006;130:1480. CrossRef

17. BrandtLJ, PratherCM, QuigleyEM, et al.Systematic review on the management of chronic constipation in North America. Am J Gastroenterol2005;100(Suppl. 1):S5. CrossRef

18. SonnenbergA, KochTR. Physician visits in the United States for constipation: 1958 to 1986. Dig Dis Sci1989;34:606. CrossRef

19. TalleyNJ. Chronic constipation and irritable bowel syndrome: epidemiology, presentation and diagnosis. Johns Hopkins Adv Stud Med2006;6:S225.

20. TalleyNJ, O'KeefeEA, ZinsmeisterAR, et al.Prevalence of gastrointestinal symptoms in the elderly: a population based study. Gastroenterology1992;102:895.

21. RaoSS, KinkadeK, SchulzeK, et al.Psychological profiles and quality of life differ in patients with dyssynergia and those with slow transit constipation. J Psychosom Res2007;63:441. CrossRef

22. DrossmanDA, LiZ, AndruzziE, et al.US householder survey of functional gastrointestinal disorders. prevalence, sociodemography and health impact. Dig Dis Sci1993;38:1569. CrossRef

23. HarariD, GurwitzJH, AvornJ, et al.Bowel habit in relation to age and gender. Findings from the National Health Interview Survey and clinical implications. Arch Intern Med1996;156:315. CrossRef

24. PekmezarisR, AversaL, Wolf‐KleinG, et al.The cost of chronic constipation. J Am Med Dir Assoc2002;3:224. CrossRef

25. ChangL, TonerBB, FukudoS, et al.Gender, age, society, culture, and the patient's perspective in the functional gastrointestinal disorders. Gastroenterology2006;130:1435. CrossRef

26. MarklandAD, PalssonO, GoodePS, et al.Association of low dietary intake of fiber and liquids with constipation: evidence from the National Health and Nutrition Examination Survey. Am J Gastroenterol2013;108:796. CrossRef

27. DerbyshireE, DaviesJ, CostarelliV, et al.Diet, physical inactivity and the prevalence of constipation throughout and after pregnancy. Matern Child Nutr2006;2:127. CrossRef

28. CoremansEA. Is there a genetic component in chronic functional constipation?Gastroenterology2005;128(Suppl. 2):S1867.

29. MudipalliRS, Remes‐TrocheJ, AndersenL, et al.Functional chest pain: esophageal or overlapping functional disorders. J Clin Gastroenterol2007;41:264. CrossRef

30. TalleyNJ, WaeverAL, ZinsmeisterAR, et al.Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol1992;136:165.

31. TalleyNJ, DennisEH, Schettler‐DuncanVA, et al.Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol2003;98:2454. CrossRef

32. LockeGR3rd, ZinsmeisterAR, FettSL, et al.Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil2005;17:29. CrossRef

33. DennisonC, PrasadM, LloydA, et al.The health‐related quality of life and economic burden of constipation. Pharmacoeconomics2005;23:461. CrossRef

34. MartinBC, BarghoutV, CerulliA. Direct medical costs of constipation in the United States. Manag Care Interface2006;19:43.

35. SinghG, LingalaV, WangH, et al.Adults with constipation account for significant use of healthcare resources and costs of care. Clin Gastroenterol Hepatol2007;5:1053. CrossRef

36. RantisPCJr, VernavaAM3rd, DanielGL, et al.Chronic constipation – is the work up worth the cost?Dis Colon Rectum1997;40:280. CrossRef

37. PeeryAF, DellonES, LundJ, et al.Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology2012;143:1179. CrossRef

38. SethiS, MikamiS, LeclairJ, et al.Inpatient burden of constipation in the United States: an analysis of national trends in the United States from 1997 to 2010. Am J Gastroenterol2014;109:250. CrossRef

39. DikVK, SiersemaPD, JosephA, et al.Constipation‐related direct medical costs in 16 887 patients newly diagnosed with chronic constipation. Eur J Gastroenterol Hepatol2014;26:1260. CrossRef

40. Bruce WirtaS, HodgkinsP, JosephA. Economic burden associated with chronic constipation in Sweden: a retrospective cohort study. Clinicoecon Outcomes Res2014;6:369. CrossRef

41. ChevalierP, LamotteM, JosephA, et al.In‐hospital costs associated with chronic constipation in Belgium: a retrospective database study. Neurogastroenterol Motil2014;26:368. CrossRef

42. CaiQ, BuonoJL, SpaldingWM, et al.Healthcare costs among patients with chronic constipation: a retrospective claims analysis in a commercially insured population. J Med Econ2014;17:148. CrossRef

43. NeriL, BasiliscoG, CorazziariE, et al.Constipation severity is associated with productivity losses and healthcare utilization in patients with chronic constipation. United European Gastroenterol J2014;2:138. CrossRef

44. GuerinA, CarsonRT, LewisB, et al.The economic burden of treatment failure amongst patients with irritable bowel syndrome with constipation or chronic constipation: a retrospective analysis of a Medicaid population. J Med Econ2014;17:577. CrossRef

45. SchmierJK, MillerPE, LevineJA, et al.Cost savings of reduced constipation rates attributed to increased dietary fiber intakes: a decision‐analytic model. BMC Public Health2014;14:374. CrossRef

46. MasonHJ, Serrano‐IkkosE, KammMA. Psychological state and quality of life in patients having behavioral treatment (biofeedback) for intractable constipation. Am J Gastroenterol2002;97:3154. CrossRef

47. NehraV, BruceBK, Rath‐HarveyDM, et al.Psychological disorders in patients with evacuation disorders and constipation in a tertiary practice. Am J Gastroenterol2000;95:1755. CrossRef

48. DrossmanDA, TalleyNJ, GelfandMD. Sexual and physical abuse and gastrointestinal illness. Review and recommendations. Ann Intern Med1995;123:782. CrossRef

49. LeroiAM, BerkelmansI, DenisP, et al.Anismus as a marker of sexual abuse. Consequences of abuse on anorectal motility. Dig Dis Sci1995;40:1411. CrossRef

50. KoloskiNA, TalleyNJ, BoycePM. Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychosocial factors. Am J Gastroenterol2001;96:1340. CrossRef

51. RingelY, WhiteheadWE, TonerBB. Sexual and physical abuse are not associated with rectal hypersensitivity in patients with irritable bowel syndrome. Gut2004;53:838. CrossRef

52. GliaA, LindbergF, NilssonLH, et al.Clinical value of symptom assessment in patients with constipation. Dis Colon Rectum1999;42:1401. CrossRef

53. IrvineEJ, FerrazziS, PareP, et al.Health‐related quality of life in functional GI disorders: focus on constipation and resource utilization. Am J Gastroenterol2002;97:1986. CrossRef

54. MertzH, NaliboffB, MayerE. Physiology of refractory chronic constipation. Am J Gastroenterol1999;94:609. CrossRef

55. KlauserAG, VoderholzerWA, HeinrichCA, et al.Behavioural modification of colonic function: can constipation be learned?Dig Dis Sci1990;35:1271. CrossRef

56. Remes‐TrocheJM, PaulsonJ, YamadaT, et al.Anorectal cortical function is impaired in patients with dyssynergic defecation. Gastroenterology2007;108:A20.

57. KarasickS, EhrlichSM. Is constipation a disorder of defecation or impaired motility? Distinction based on defecography and colonic transit studies. Am J Roentgenol1996;166:63. CrossRef

58. NullensS, NelsenT, CamilleriM, et al.Regional colon transit in patients with dys‐synergic defaecation or slow transit in patients with constipation. Gut2012;61:1132. CrossRef

59. CashBD, CheyWD. Diagnosis of irritable bowel syndrome. Gastroenterol Clin North Am2005;34:vi.

60. TillischK, ChangL. Diagnosis and treatment of irritable bowel syndrome: state of the art. Curr Gastroenterol Rep2005;7:249. CrossRef

61. AttaluriA. Is methanogenic flora associated with chronic constipation and altered colonic transit and stool characteristics?Gastroenterology2007;132(Suppl. 2):T1945.

62. PimentelM, ChowEJ, LinHC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol2000;95:3503. CrossRef

63. PimentelM, ParkS, MirochaJ, et al.The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med2006;145:557. CrossRef

64. SarnaSK. Physiology and pathophysiology of colonic motor activity. Part 2. Dig Dis Sci1991;36:998. CrossRef

65. BassottiG, BettiC, ImbimboBP, et al.Colonic motor response to eating: a manometric investigation in proximal and distal portion of the viscus in man. Am J Gastroenterol1989;84:118.

66. RaoSS, KavelockR, BeatyJ, et al.Effects of fat and carbohydrate meals on colonic motor response. Gut2000;46:205. CrossRef

67. RaoSS, SadeghiP, BeatyJ, et al.Ambulatory 24‐h colonic manometry in healthy humans. Am J Physiol Gastrointest Liver Physiol2001;280:G629.

68. RaoSS, BeatyJ, ChamberlainM, et al.Effects of acute graded exercise on human colonic motility. Am J Physiol1999;276:G1221.

69. ChaudharyNA, TrueloneSC. Human colonic motility: a comparative study of normal subjects, patients with ulcerative colitis and patients with irritable bowel syndrome. a resting pattern of motility. Gastroenterology1961;40:11.

70. NarducciF, SnapeWJ, BattleWM, et al.Increased colonic motility during exposure to a stressful situation. Dig Dis Sci1985;30:40. CrossRef

71. RaoSS, SadeghiP, BeatyJ, et al.Ambulatory 24‐h colonic manometry in slow‐transit constipation. Am J Gastroenterol2004;99:2405. CrossRef

72. BassottiG, de RobertoG, CastellaniD, et al.Normal aspects of colorectal motility and abnormalities in slow transit constipation. World J Gastroenterol2005;11:2691. CrossRef

73. RaoSS, SadeghiP, KavlockR, et al.Specialized propagating contractions (SPC) in health and constipation. Gastroenterology1999;116:G4635.

74. HervéS, SavoyeG, BehbahaniA, et al.Results of 24‐h manometric recording of colonic motor activity with endoluminal instillation of bisacodyl in patients with severe chronic slow transit constipation. Neurogastroenterol Motil2004;16:397. CrossRef

75. RodriguezL, NurkoS, FloresA. Factors associated with successful decrease and discontinuation of antegrade continence enemas (ACE) in children with defecation disorders: a study evaluating the effect of ACE on colon motility. Neurogastroenterol Motil2013;25:140. CrossRef

76. BriejerMR, PrinsNH, SchuurkesJA. Effects of the enterokinetic prucalopride (R093877) on colonic motility in fasted dogs. Neurogastroenterol Motil2001;13:465. CrossRef

77. MinerP, CamilleriM, BurtonD, et al.Prucalopride induces high amplitude propagated contractions in the colon: a randomized, crossover, reader‐blinded study. Neurogastroenterol Motil2015;27(Suppl. 2):86.

78. BassottiG, ChirarioniG, VantiniI, et al.Anorectal manometric abnormalities and colonic propulsive impairment in patients with severe chronic idiopathic constipation. Dig Dis Sci1994;39:1558. CrossRef

79. RaoSS, WelcherK. Periodic rectal motor activity: the intrinsic colonic gatekeeper?Am J Gastroenterol1996;91:890.

80. RaoSS, SadeghiP, BattersonK, et al.Altered periodic rectal motor activity: a mechanism for slow transit constipation. Neurogastroenterol Motil2001;13:591. CrossRef

81. OrkinBA, HansonRB, KellyKA. The rectal motor complex. Gastrointest Motil1989;1:5. CrossRef

82. ReadNW, SunWM. Coloproctology and pelvic floor. In: HenryM, SwashM(eds). Anorectal Manometry, 2nd edn. London: Buuterworths, 1992: 119.

83. BharuchaAE, PhillipsSF. Slow transit constipation. Gastroenterol Clin North Am2001;30:77. CrossRef

84. LawNM, BharuchaAE, ZinsmeisterAR. Rectal and colonic distension elicit viscerovisceral reflexes in humans. Am J Physiol Gastrointest Liver Physiol2002;283:G384. CrossRef

85. O'BrienMD, CamilleriM, von der OheMR, et al.Motility and tone of the left colon in constipation: a role in clinical practice?Am J Gastroenterol1996;91:2532.

86. BamptonPA, DinningPG, KennedyML, et al.Spatial and temporal organization of pressure patterns throughout the unprepared colon during spontaneous defecation. Am J Gastroenterol2000;95:1027. CrossRef

87. BassottiG, IantornoG, FiorellaS, et al.Colonic motility in man: features in normal subjects and in patients with chronic idiopathic constipation. Am J Gastroenterol1999;94:1760. CrossRef

88. De SchryverAM, SamsomM, SmoutAI. Effects of a meal and bisacodyl on colonic motility in healthy volunteers and patients with slow‐transit constipation. Dig Dis Sci2003;48:1206. CrossRef

89. KnowlesCH, ScottSM, WellmerA, et al.Sensory and autonomic neuropathy in patients with idiopathic slow‐transit constipation. Br J Surg1999;86:54. CrossRef

90. EmmanuelAV, KammMA. Laser Doppler flowmetry as a measure of extrinsic colonic innervation in functional bowel disease. Gut2000;46:212. CrossRef

91. SurrentiE, RathDM, PembertonJH, et al.Audit of constipation in a tertiary referral gastroenterology practice. Am J Gastroenterol1995;90:1471.

92. HeCL, BurgartL, WangL, et al.Decreased interstitial cell of cajal volume in patients with slow‐transit constipation. Gastroenterology2000;118:14. CrossRef

93. LyfordGL, HeCL, SofferE, et al.Pan‐colonic decrease in interstitial cells of Cajal in patients with slow transit constipation. Gut2002;51:496. CrossRef

94. SandersKM. A case for interstitial cells of Cajal as pacemakers and mediators of neurotransmission in the gastrointestinal tract. Gastroenterology1996;111:492. CrossRef

95. TakakiM. Gut pacemaker cells: the interstitial cells of Cajal (ICC). J Smooth Muscle Res2003;39:137. CrossRef

96. HananiM, FreundHR. Interstitial cells of Cajal – their role in pacing and signal transmission in the digestive system. Acta Physiol Scand2000;170:177. CrossRef

97. YuCS, KimHC, HongHK, et al.Evaluation of myenteric ganglion cells and interstitial cells of Cajal in patients with chronic idiopathic constipation. Int J Colorectal Dis2002;17:253. CrossRef

98. MollenRM, HopmanWP, KuijpersHH, et al.Abnormalities of upper gut motility in patients with slow‐transit constipation. Eur J Gastroenterol Hepatol1999;11:701. CrossRef

99. SpillerRC. Upper gut dysmotility in slow‐transit constipation: is it evidence for a pan‐enteric neurological deficit in severe slow transit constipation?Eur J Gastroenterol Hepatol1999;11:693. CrossRef

100. DevroedeG, SoffieM. Colonic absorption in idiopathic constipation. Gastroenterology1973;64:552.

101. PrestonDM, Lennard‐JonesJ. Severe chronic constipation of young women: idiopathic slow transit constipation?Gut1986;27:41. CrossRef

102. KammMA, FarthingMJ, Lennard‐JonesJE, et al.Steroid hormone abnormalities in women with severe idiopathic constipation. Gut1991;32:80. CrossRef

103. KammMA, FarthingMJ, Lennard‐JonesJE. Bowel function and transit rate during the menstrual cycle. Gut1989;30:605. CrossRef

104. WaldA, Van ThielDH, HoechstetterL, et al.Gastrointestinal transit: the effect of the menstrual cycle. Gastroenterology1981;80:1497.

105. TurnbullGK, ThompsonDG, DayS, et al.Relationships between symptoms, menstrual cycle and orocaecal transit in normal and constipated women. Gut1989;30:30. CrossRef

106. KammMA. Pathophysiology of constipation. In: PhillipsSF, PembertonJH, ShorterRG(eds). The Large Intestine. Physiology, Pathophysiology and Disease. New York: Raven Press, 1991: 709.

107. KochTR, CarneyJA, GoL, et al.Idiopathic chronic constipation is associated with decreased colonic vasoactive intestinal peptide. Gastroenterology1988;94:300.

108. LincolnJ, CroweR, KammMA, et al.Serotonin and 5‐hydroxyindoleacetic acid are increased in the sigmoid colon in severe idiopathic constipation. Gastroenterology1990;98:1219.

109. PrestonDM, AdrianTE, ChristofidesND, et al.Positive correlation between symptoms and circulating motilin, pancreatic polypeptide and gastrin concentrations in functional bowel disorders. Gut1985;26:1059. CrossRef

110. Muller‐LissnerSA, KammMA, ScarpignatoC, et al.Myths and misconceptions about chronic constipation. Am J Gastroenterol2005;100:232. CrossRef

111. XiaoZL, CaoW, BiancaniP, et al.Nongenomic effects of progesterone on the contraction of muscle cells from the guinea pig colon. Am J Physiol Gastrointest Liver Physiol2006;290:G1008. CrossRef

112. XiaoZL, PricoloV, BiancaniP, et al.Role of progesterone signaling in the regulation of G‐protein levels in female chronic constipation. Gastroenterology2005;128:667. CrossRef

113. PimentelM, LinHC, EnayatiP, et al.Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. Am J Physiol Gastrointest Liver Physiol2006;290:G1089. CrossRef

114. GershonMD. Review article: serotonin receptors and transporters – roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther2004;20(Suppl. 7):3. CrossRef

115. GriderJR, KuemmerleJF, JinJG. 5‐HT released by mucosal stimuli initiates peristalsis by activating 5‐HT4/5‐HT1p receptors on sensory CGRP neurons. Am J Physiol1996;270:G778.

116. GriderJR, Foxx‐OrensteinAE, Ji‐GuangJ. 5‐Hydroxytryptamine4 receptor agonist initiate the peristaltic reflex in human, rat, and guinea pig intestine. Gastroenterology1998;115:370. CrossRef

117. PratherCM, CamilleriM, ZinsmeisterAR, et al.Tegaserod accelerates orocecal transit in patients with constipation‐predominant irritable bowel syndrome. Gastroenterology2000;118:463. CrossRef

118. BjornssonES, CheyWD, HooperF, et al.Impaired gastrocolonic response and peristaltic reflex in slow‐transit constipation: role of 5‐HT(3) pathways. Am J Physiol Gastrointest Liver Physiol2002;283:G400. CrossRef

119. CostedioMM, HymanN, MaweGM. Serotonin and its role in colonic function and in gastrointestinal disorders. Dis Colon Rectum2007;50:376. CrossRef

120. RaoSS, WelcherKD, LeistikowJS. Obstructive defecation: a failure of rectoanal coordination. Am J Gastroenterol1998;93:1042. CrossRef

121. GladmanMA, ScottSM, WilliamsNS, et al.Clinical and physiological findings and possible aetiological factors of rectal hyposensitivity. Br J Surg2003;90:860. CrossRef

122. RaoSS. Advances in diagnostic assessment of fecal incontinence and dyssynergic defecation. Clin Gastroenterol Hepatol2010;8:910. CrossRef

123. PrestonDM, Lennard‐JonesJE. Anismus in chronic constipation. Dig Dis Sci1985;30:413. CrossRef

124. MartelliH, DevroedeG, ArhanP, et al.Mechanisms of idiopathic constipation: outlet obstruction. Gastroenterology1978;75:623.

125. BleijenbergG, KuijpersHC. Treatment of spastic pelvic floor syndrome with biofeedback. Dis Colon Rectum1987;30:101. CrossRef

126. DuthieGS, BartoloDCC. Anismus: the cause of constipation? Results of investigation and treatment. World J Surg1992;16:831. CrossRef

127. RaoSS, HatfieldR, SofferE, et al.Manometric tests of anorectal function in healthy adults. Am J Gastroenterol1999;94:773. CrossRef

128. RaoSS, KavlockR, RaoS. Influence of body position and stool characteristics on defecation in humans. Am J Gastroenterol2006;101:2790. CrossRef

129. PinhoM, YoshiokaK, KeighleyMRB. Long term results of anorectal myectomy for chronic constipation. Br J Surg1989;76:1163. CrossRef

130. HallanRI, WilliamsNS, MellingJ, et al.Treatment of animus in intractable constipation with botulinum A toxin. Lancet1988;ii:714. CrossRef

131. RonY, AvniY, LukovetskiA, et al.Botulinum toxin type‐A in therapy of patients with anismus. Dis Colon Rectum2001;44:1821. CrossRef

132. RaoSS, MudipalliRS, StessmanM, et al.Investigation of the utility of colorectal function tests and Rome II criteria in dyssynergic defecation (anismus). Neurogastroenterol Motil2004;16:589. CrossRef

133. PaulsonJ, MillerMJ, StessmanM, et al.Influence of dyssynergia type on the outcome of biofeedback therapy (BT). Neurogastroenterol Motil2005;17:605.

134. RaoSS. The technical aspects of biofeedback therapy for defecation disorders. Gastroenterologist1998;6:96.

135. BrocklehurstJC. Colonic disease in the elderly. Clin Gastroenterol1985;14:725.

136. RattanS, ReganRF, PatelCA, et al.Nitric oxide not carbon monoxide mediates nonadrenergic noncholinergic relaxation in the murine internal anal sphincter. Gastroenterology2005;129:1954. CrossRef

137. TobonF, ReidNC, TalbertJL, et al.Nonsurgical test for the diagnosis of Hirschsprung's disease. N Engl J Med1968;278:188. CrossRef

138. GathR, GoesslingA, KellerKM, et al.Analysis of the RET, GDNF, EDN3, and EDNRB genes in patients with intestinal neuronal dysplasia and Hirschsprung disease. Gut2001;48:671. CrossRef

139. CrowellMD, HarrisL, JonesMP, et al.New insights into the pathophysiology of irritable bowel syndrome: implications for future treatments. Curr Gastroenterol Rep2005;7:272. CrossRef

140. American Gastroenterological Association. American Gastroenterological Association medical position statement: irritable bowel syndrome. Gastroenterology2002;123:2105. CrossRef

141. De PalmaG, CollinsSM, BercikP. The microbiota‐gut‐brain axis in functional gastrointestinal disorders. Gut Microbes2014;5:419. CrossRef

142. Wilder‐SmithCH, SchindlerD, LovbladK, et al.Brain functional magnetic resonance imaging of rectal pain and activation of endogenous inhibitory mechanisms in irritable bowel syndrome patient subgroups and healthy controls. Gut2004;53:1595. CrossRef

143. CamilleriM. Peripheral mechanisms in irritable bowel syndrome. N Engl J Med2012;367:1626. CrossRef

144. LockeGRIII, WeaverAL, MeltonLJIII, et al.Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case‐control study. Am J Gastroenterol2004;99:350. CrossRef

145. KochA, VoderholzerWA, KlauserAG, et al.Symptoms in chronic constipation. Dis Colon Rectum1997;40:902. CrossRef

146. HeatonKW, RadvanJ, CrippsH, et al.Defecation frequency and timing, and stool form in the general population: a prospective study. Gut1992;33:818. CrossRef

147. O'DonnellLJ, VirjeeJ, HeatonKW. Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate. BMJ1990;300:439. CrossRef

148. FoldenSL. Practice guidelines for the management of constipation in adults. Rehabil Nurs2002;27:169. CrossRef

149. HeatonKW, WoodN, CrippsHA, et al.The call to stool and its relationship to constipation: a community study. Eur J Gastroenterol Hepatol1994;6:145. CrossRef

150. RaoP, TantiphlachivaK, AttaluriA, et al.How useful is digital rectal examination in the diagnosis of dyssynergia?Am J Gastroenterol2007;102:51.

151. LawrentschukN, BoltonDM. Experience and attitudes of final‐year medical students to digital rectal examination. Med J Aust2004;181:323.

152. TantiphlachivaK, RaoP, AttaluriA, et al.Digital rectal examination is a useful tool for identifying patients with dyssynergia. Clin Gastroenterol Hepatol2010;8:955. CrossRef

153. RaoSS, OzturkR, LaineL. Clinical utility of diagnostic tests for constipation in adults: a systematic review. Am J Gastroenterol2005;100:1605. CrossRef

154. BrandtLJ, SchoenfeldP, PratherCM, et al.Evidence‐based position statement on the management of chronic constipation in North America. Am J Gastroenterol2005;100:S1. CrossRef

155. van den BoschM, GraafmansD, NievelsteinR, et al.Systematic assessment of constipation on plain abdominal radiographs in children. Pediatr Radiol2006;36:224. CrossRef

156. Reuchlin‐VroklageLM, Bierma‐ZeinstraS, BenningaMA, et al.Diagnostic value of abdominal radiography in constipated children: a systematic review. Arch Pediatr Adolesc Med2005;159:671. CrossRef

157. PatriquinH, MartelliH, DevroedeG. Barium enema in chronic constipation: is it meaningful?Gastroenterology1978;75:619.

158. GersonDE, LewickiAM, McNeilBJ, et al.The barium enema; evidence for proper utilization. Radiology1979;130:297. CrossRef

159. QureshiW, AdlerDG, DavilaRE, et al.ASGE guideline: guideline on the use of endoscopy in the management of constipation. Gastrointest Endosc2005;62:199. CrossRef

160. PepinC, LadabaumU. The yield of lower endoscopy in patients with constipation: survey of a university hospital, a public county hospital, and a Veterans Administration medical center. Gastrointest Endosc2002;56:325. CrossRef

161. EvansRC, KammMA, HintonJM, et al.The normal range and simple diagram of recording whole gut transit time. Int J Colorectal Dis1992;1:15. CrossRef

162. StivlandT, CamilleriM, VassalloM, et al.Scintigraphic measurement of regional gut transit in idiopathic constipation. Gastroenterology1991;101:107.

163. van der SijpJR, KammMA, NightingaleJM, et al.Radioisotope determination of regional colonic transit in severe constipation: comparison with radio opaque markers. Gut1993;34:402. CrossRef

164. RaoSS, KuoB, McCallumR, et al.Investigation of wireless motility capsule for colonic and whole gut transit: a comparative study with radioopaque markers in health and constipation. Clin Gastroenterol Hepatol2009;7: 537. CrossRef

165. NamYS, PikarskyAJ, WexnerSD, et al.Reproducibility of colonic transit study in patients with chronic constipation. Dis Colon Rectum2001;44:86. CrossRef

166. HintonJM, Lennard‐JonesJE, YoungAC. A new method for studying gut transit times using radio‐opaque markers. Gut1969;24:123.

167. EhrenpreisED, JorgeJMN, SchianoTD, et al.Why colonic marker studies don't measure transit time. Gastroenterology1997;110A:728.

168. LundinE, KarlbomU, PahlmanL, et al.Outcome of segmental colonic resection for slow‐transit constipation. Br J Surg2002;89:1270. CrossRef

169. ShinA, CamilleriM, NadeauA, et al.Interpretation of overall colonic transit in defecation disorders in males and females. Neurogastroenterol Motil2013;25:502. CrossRef

170. CamilleriM, ThorneN, RingelY, et al.Wireless pH‐motility capsule for colonic transit: prospective comparison with radiopaque markers in chronic constipation. Neurogastroenterol Motil2010;22:874. CrossRef

171. RaoSS, Coss‐AdameE, ValestinJ, et al.Evaluation of constipation in older adults: radioopaque markers (ROMs) versus wireless motility capsule (WMC). Arch Gerontol Geriatr2012;55:289. CrossRef

172. RaoSSC, CamilleriM, ParkmanH, et al.Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies. Neurogastroenterol Motil2011;23:8. CrossRef

173. RaoSS, MysoreK, AttaluriA, et al.Diagnostic utility of wireless motility capsule in gastrointestinal dysmotility. J Clin Gastroenterol2011;45:684. CrossRef

174. RaoSS, PatelRS. How useful are manometric tests of anorectal function in the management of defecation disorders?Am J Gastroenterol1997;92:469.

175. KarlbomU, LundinE, GrafW, et al.Anorectal physiology in relation to clinical subgroups of patients with severe constipation. Colorectal Dis2004;6:343. CrossRef

176. ReidJR, BuonomoC, MoreiraC, et al.The barium enema in constipation: comparison with rectal manometry and biopsy to exclude Hirschsprung's disease after the neonatal period. Pediatr Radiol2000;30:681. CrossRef

177. De LorijnF, ReitsmaJB, VoskuijlWP, et al.Diagnosis of Hirschsprung's disease: a prospective, comparative accuracy study of common tests. J Pediatr2005;146:787. CrossRef

178. GladmanMA, DvorkinLS, LunnissOJ, et al.Rectal hyposensitivity: a disorder of the rectal wall or the afferent pathway? An assessment using the barostat. Am J Gastroenterol2005;100:106. CrossRef

179. GladmanMA, LunnissPJ, ScottSM, et al.Rectal hyposensitivity. Am J Gastroenterol2006;101:1140. CrossRef

180. GladmanMA, ScottSM, WilliamsNS, et al.Clinical and physiological findings, and possible aetiological factors of rectal hyposensitivity. Br J Surg2003;90:860. CrossRef

181. RaoSS, AzpirozF, DiamantN, et al.Minimum standards of anorectal manometry. Neurogastroenterol Motil2002;14:553. CrossRef

182. JonesMP, PostJ, CrowellMD. High‐resolution manometry in the evaluation of anorectal disorders: a simultaneous comparison with water‐perfused manometry. Am J Gastroenterol2007;102:850. CrossRef

183. MinguezM, HerrerosB, SanchizV, et al.Predictive value of the balloon expulsion test for excluding the diagnosis of pelvic floor dyssynergia in constipation. Gastroenterology2004;126:57. CrossRef

184. ChiarioniG, KimSM, VantiniI, et al.Validation of the balloon evacuation test: reproducibility and agreement with findings from anorectal manometry and electromyography. Clin Gastroenterol Hepatol2014;12:2049. CrossRef

185. Savoye‐ColletC, SavoyeG, KoningE, et al.Defecography in symptomatic older women living at home. Age Ageing2003;32:347. CrossRef

186. DinningPG, WiklendtL, GibbinsI, et al.Low‐resolution colonic manometry leads to a gross misinterpretation of the frequency and polarity of propagating sequences: Initial results from fiber‐optic high‐resolution manometry studies. Neurogastroenterol Motil2013;25:e640.

187. GertkenJT, CocjinJ, PehlivanovN, et al.Comorbidities associated with constipation in children referred for colon manometry may mask functional diagnoses. J Pediatr Gastroenterol Nutr2005;41:328. CrossRef

188. SinghS, HeadyS, Coss‐AdameE, et al.Clinical utility of colonic manometry in slow transit constipation. Neurogastroenterol Motil2013;25:487. CrossRef

189. DvorkinLS, HetzerF, ScottSM, et al.Open‐magnet MR defaecography compared with evacuation proctography in the diagnosis and management of patients with rectal intussusception. Colorectal Dis2004;6:45. CrossRef

190. FletcherJG, BusseRF, RiedererSJ, et al.Magnetic resonance imaging of anatomic and dynamic defects of the pelvic floor in defecatory disorders. Am J Gastroenterol2003;98:399. CrossRef

191. RoosJE, WeishauptD, WildermuthS, et al.Experience of 4 years with open MR defecography: pictorial review of anorectal anatomy and disease. Radiographics2002;22:817. CrossRef

192. BologN, WeishauptD. Dynamic MR imaging of outlet obstruction. Rom J Gastroenterol2005;14:293.

193. BertschingerKM, HetzerFH, RoosJE, et al.Dynamic MR imaging of the pelvic floor performed with patient sitting in an open‐magnet unit versus with patient supine in a closed‐magnet unit. Radiology2002;223:501. CrossRef

194. BharuchaAE, FletcherJG, SeideB, et al.Phenotypic variation in functional disorders of defecation. Gastroenterology2005;128:1199. CrossRef

195. SchreyerAG, PaetzelC, FürstA, et al.Dynamic magnetic resonance defecography in 10 asymptomatic volunteers. World J Gastroenterol2012;18:6836. CrossRef

196. PilkingtonSA, NugentKP, BrennerJ, et al.Barium proctography vs magnetic resonance proctography for pelvic floor disorders: a comparative study. Colorectal Dis2012;14:1224. CrossRef

197. SchillerLR, DennisE, TothG. Primary care physicians consider constipation as a severe and bothersome medical condition that negatively impacts patients' lives. Am J Gastroenterol2004;99:S234.

198. JohansonJF, KralsteinJ. Chronic constipation: a survey of the patient perspective. Aliment Pharmacol Ther2007;25:599. CrossRef

199. BiL, TriadafilopoulosG. Exercise and gastrointestinal function and disease: an evidence‐based review of risks and benefits. Clin Gastroenterol Hepatol2003;1:345. CrossRef

200. BrownWJ, MishraG, LeeC, et al.Leisure time physical activity in Australian women: relationship with well being and symptoms. Res Q Exerc Sport2000;71:206. CrossRef

201. KinnunenO. Study of constipation in a geriatric hospital, day hospital, old people's home and at home. Aging (Milano)1991;3:161.

202. AntiM, PignataroG, ArmuzziA, et al.Water supplementation enhances the effect of high‐fiber diet on stool frequency and laxative consumption in adult patients with functional constipation. Hepatogastroenterology1998;45:727.

203. DupontC, CampagneA, ConstantF. Efficacy and safety of a magnesium sulfate‐rich natural mineral water for patients with functional constipation. Clin Gastroenterol Hepatol2014;12:1280. CrossRef

204. RutlandT, Di PalmaJ. Prevalence of medication‐associated constipation. Am J Gastroenterol2004;99(Suppl.):S103.

205. RadbruchL, SabatowskiR, LoickG, et al.Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine. Palliat Med2000;14:111. CrossRef

206. YuanCS, FossJF. Oral methylnaltrexone for opioid‐induced constipation. JAMA2000;284:1383. CrossRef

207. CamilleriM. Opioid‐induced constipation: challenges and therapeutic opportunities. Am J Gastroenterol2011;106:835. CrossRef

208. CheyWD, WebsterL, SostekM, et al.Naloxegol for opioid‐induced constipation in patients with noncancer pain. N Engl J Med2014;370:2387. CrossRef

209. SchillerLR. Review article: the therapy of constipation. Aliment Pharmacol Ther2001;15:749. CrossRef

210. BurkittDP, WalkerARP, PainterNS. Effect of dietary fiber on stool and transit times and its role in the causation of disease. Lancet1972;ii:1408. CrossRef

211. TuckerDM, SandsteadHH, LoganGM. Dietary fiber and personality factors as determinants of stool output. Gastroenterology1981;81:879.

212. VoderholzerWA, SchatkeW, MuhldorferBE, et al.Clinical response to dietary fiber treatment of chronic constipation. Am J Gastroenterol1997;92:95.

213. RamkumarD, RaoSSC. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol2005;100:936. CrossRef

214. AttaluriA, DonahoeR, ValestinJ, et al.Randomised clinical trial: dried plums (prunes) vs. psyllium for constipation. Aliment Pharmacol Ther2011;33:822. CrossRef

215. ChunAB, SokolMS, KayeWH, et al.Colonic and anorectal function in constipated patients with anorexia nervosa. Am J Gastroenterol1997;92:1879.

216. ChiarioniG, BassottiG, MonsignoriA, et al.Anorectal dysfunction in constipated women with anorexia nervosa. Mayo Clin Proc2000;75:1015. CrossRef

217. KlineC. Non Prescription Drugs USA. Little Falls, NJ: Kline, 2000.

218. SinghS, RaoSS. Pharmacologic management of chronic constipation. Gastroenterol Clin North Am2010;39:509. CrossRef

219. WaldA. Approach to the patient with constipation. In: YamadaT, AlpersDH, OwyangC, et al. (eds). Textbook of Gastroenterology. Philadelphia: J.B. Lippincott Co, 1991: 779.

220. DiPalmaJA. Current treatment options for chronic constipation. Rev Gastroenterol Disord2004;4(Suppl. 2):S34.

221. SiegelJ, Di PalmaJ. Medical treatment of constipation. Clin Colon Rectal Surg2005;18:76. CrossRef

222. KammMA, Mueller‐LissnerS, WaldA, et al.Oral Bisacodyl is effective and well‐tolerated in patients with chronic constipation. Clin Gastroenterol Hepatol2011;9:577. CrossRef

223. KinnunenO, SalokannelJ. Constipation in elderly long‐stay patients: its treatment by magnesium hydroxide and bulk‐laxative. Ann Clin Res1987;19:321.

224. HammerHF, Santa AnaCA, SchillerLR, et al.Studies of osmotic diarrhea induced in normal subjects by ingestion of polyethylene glycol and lactulose. J Clin Invest1989;84:1056. CrossRef

225. LederleFA. Epidemiology of constipation in elderly patients. Drug utilization and cost containment strategies. Drugs Aging1995;6:465. CrossRef

226. DiPalmaJA, DeRidderPH, OrlandoRC, et al.A randomized, placebo‐controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative. Am J Gastroenterol2000;95:341. CrossRef

227. ToledoTK, DiPalmaJA. Review article: colon cleansing preparation for gastrointestinal procedures. Aliment Pharmacol Ther2001;15:605. CrossRef

228. CorazziariE, BadialiD, BazzocchiG, et al.Long term efficacy, safety, and tolerabilitity of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF‐100) in the treatment of functional chronic constipation. Gut2000;46:522. CrossRef

229. Di PalmaJ. A randomized, multi‐center, placebo controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation. Am J Gastroenterol2007;102:1436. CrossRef

230. CashBD, CheyWD. Review article: the role of serotonergic agents in the treatment of patients with primary chronic constipation. Aliment Pharmacol Ther2005;22:1047. CrossRef

231. ShinA, CamilleriM, KolarG, et al.Systematic review with meta‐analysis: highly selective 5‐HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation. Aliment Pharmacol Ther2014;39:239. CrossRef

232. CuppolettiJ, MalinowskaDH, TewariKP, et al.SPI‐0211 activates T84 cell chloride transport and recombinant human ClC‐2 chloride currents. Am J Physiol Cell Physiol2004;287:C1173. CrossRef

233. LipeckaJ, BaliM, ThomasA, et al.Distribution of ClC‐2 chloride channel in rat and human epithelial tissues. Am J Physiol Cell Physiol2002;282:C805. CrossRef

234. CamilleriM, BharuchaAE, UenoR, et al.Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol2006;290:G942. CrossRef

235. JohansonJF, MortonD, GeenenJ, et al.Multicenter, 4‐week, double‐blind, randomized, placebo‐controlled trial of lubiprostone, a locally‐acting type‐2 chloride channel activator, in patients with chronic constipation. Am J Gastroenterol2008;103:170. CrossRef

236. JohansonJF, UenoR. Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a doubleblind, placebo‐controlled, dose‐ranging study to evaluate efficacy and safety. Aliment Pharmacol Ther2007;25:1351. CrossRef

237. JohansonJF, HollandPC, UenoR. Long‐term efficacy of lubiprostone for the treatment of chronic constipation. Gastroenterology2006;130:M1171.

238. Lubiprostone: RU 0211, SPI 0211. Drugs2005;6:245.

239. CryerB, KatzS, VallejoR, et al.A randomized study of lubiprostone for opioid‐induced constipation in patients with chronic noncancer pain. Pain Med2014;15:1825. CrossRef

240. AndresenV, CamilleriM, BusciglioIA, et al.Effect of 5 days linaclotide on transit and bowel function in females with constipation‐predominant irritable bowel syndrome. Gastroenterology2007;133:761. CrossRef

241. LemboAJ, KurtzCB, MacdougallJE, et al.Efficacy of linaclotide for patients with chronic constipation. Gastroenterology2010;138:886. CrossRef

242. LemboAJ, SchneierHA, ShiffSJ, et al.Two randomized trials of linaclotide for chronic constipation. N Engl J Med2011;365:527. CrossRef

243. CastroJ, HarringtonAM, HughesPA, et al.Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase‐C and extracellular cyclic guanosine 3′,5′‐monophosphate. Gastroenterology2013;145:1334. CrossRef

244. RaoS, LemboAJ, ShiffSJ, et al.A 12‐week, randomized, controlled trial with a 4‐week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation. Am J Gastroenterol2012;107:1714. CrossRef

245. VerneGN, EakerEY, DavidRD. Colchicine is an effective treatment for patients with severe idiopathic constipation. Gastroenterology1995;108:A705.

246. RoartyTP, WeberF, SoykanI, et al.Misoprostol in the treatment of chronic refractory constipation: results of a long‐term open label trial. Aliment Pharmacol Ther1997;11:1059. CrossRef

247. ShailubhaiK, TallutoC, ComiskeyS, et al.Phase II clinical evaluation of SP‐304, a guanylate cyclase‐C agonist, for treatment of chronic constipation. Am J Gastroenterol2010;105:S487.

248. MinerP, SurowitzR, FogelR, et al.Plecanatide, a novel guanylate cyclase‐C (GC‐C) receptor agonist, is efficacious and safe in patients with chronic idiopathic constipation (CIC): results from a 951 patient, 12‐week, multi‐center trial. Gastroenterology2013;144(5 Suppl. 1):S163. CrossRef

249. WongB, CamilleriM, McKinzieS, et al.Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation. Am J Gastroenterol2011;106:2154. CrossRef

250. CheyWD, CamilleriM, ChangL, et al.A randomized placebo‐controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation. Am J Gastroenterol2011;106:1803. CrossRef

251. ChiarioniG, SalandiniL, WhiteheadWE. Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation. Gastroenterology2005;129:86. CrossRef

252. ChiarioniG, WhiteheadWE, PezzaV, et al.Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia. Gastroenterology2006;130:657. CrossRef

253. RaoSS, SeatonK, MillerM, et al.Randomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecation. Clin Gastroenterol Hepatol2007;5:331. CrossRef

254. PinhoM, YoshiokaK, KeighleyMR. Long term results of anorectal myectomy for chronic constipation. Br J Surg1989;76:1163. CrossRef

255. PelsangRE, RaoSS, WelcherK. FECOM: a new artificial stool for evaluating defecation. Am J Gastroenterol1999;94:183. CrossRef

256. RaoSS, KinkadeK, MillerMJ, et al.Randomized controlled trial of long term outcome of biofeedback therapy (BT) for dyssynergic defecation. Am J Gastroenterol2005;100:386.

257. KawimbeBM, PapachrysostomouM, BinnieNR, et al.Outlet obstruction constipation (anismus) managed by biofeedback. Gut1991;32:1175. CrossRef

258. RaoSS, EnckP, Loening‐BauckeV. Biofeedback therapy for defecation disorders. Dig Dis1997;15(Suppl. 1):78. CrossRef

259. PapachrysostomouM, SmithAN. Effects of biofeedback on obstructive defecation – reconditioning of the defecation reflex?Gut1994;35:242. CrossRef

260. HeymenS, WexnerSD, VickersD, et al.Prospective, randomized trial comparing for biofeedback techniques for patients with constipation. Dis Colon Rectum1999;42:1388. CrossRef

261. PatankarSK, FerraraA, LevyJR, et al.Biofeedback in colorectal practice: a multicenter, statewide, three‐year experience. Dis Colon Rectum1997;40:827. CrossRef

262. NyamDC, PembertonJH, IlstrupDM, et al.Long‐term results of surgery for chronic constipation. Dis Colon Rectum1997;40:273. CrossRef

263. RedmondJM, SmithGW, BarofskyI, et al.Physiological tests to predict long‐term outcome of total abdominal colectomy for intractable constipation. Am J Gastroenterol1995;90:748.

264. HassanI, PembertonJH, Young‐FadokTM, et al.Ileorectal anastomosis for slow transit constipation: long‐term functional and quality of life results. J Gastrointest Surg2006;10:1330, discussion 1336. CrossRef

265. TackettLD, MinevichE, BenedictJF, et al.Appendiceal versus ileal segment for antegrade continence enema. J Urol2002;167:683. CrossRef

266. RiveraMT, KugathasanS, BergerW, et al.Percutaneous colonoscopic cecostomy for management of chronic constipation in children. Gastrointest Endosc2001;53:225. CrossRef

267. LeesNP, HodsonP, HillJ, et al.Long‐term results of the antegrade continent enema procedure for constipation in adults. Colorectal Dis2004;6:362. CrossRef

268. PembertonJH, RathDM, IlstrupDM. Evaluation and surgical treatment of severe chronic constipation. Ann Surg1991;214:403. CrossRef

269. GhoshS, PapachrysostomouM, BatoolM, et al.Longterm results of subtotal colectomy and evidence of noncolonic involvement in patients with idiopathic slow‐transit constipation. Scand J Gastroenterol1996;31:1083. CrossRef

270. HoYH, TanM, Seow‐ChoenF. Prospective randomized controlled study of clinical function and anorectal physiology after low anterior resection: comparison of straight and colonic J pouch anastomoses. Br J Surg1996;83:978. CrossRef

271. PrestonDM, HawleyPR, Lennard‐JonesJE, et al.Results of colectomy for severe idiopathic constipation in women (Arbuthnot Lane's disease). Br J Surg1984;71:547. CrossRef

272. van der SijpJR, KammMA, BartramCI, et al.The value of age of onset and rectal emptying in predicting the outcome of colectomy for severe idiopathic constipation. Int J Colorectal Dis1992;7:35. CrossRef

273. RotholtzNA, WexnerSD. Surgical treatment of constipation and fecal incontinence. Gastroenterol Clin North Am2001;30:131. CrossRef

274. AltomareDF, RinalkiM, VegliaA, et al.Combined perineal and endorectal repair of rectocele by circular stapler: a novel surgical technique. Dis Colon Rectum2002;45:1549. CrossRef

275. KeighleyMR, ShoulerP. Clinical and manometric features of the solitary rectal ulcer syndrome. Dis Colon Rectum1984;27:507. CrossRef

276. RaoSS, StessmanM, De OcampoS, et al.Pathophysiology and role of biofeedback therapy in solitary rectal ulcer syndrome. Am J Gastroenterol2006;101:613. CrossRef

277. ArroyoA, Perez‐VicenteF, SerranoP, et al.Evaluation of the stapled transanal rectal resection technique with two staplers in the treatment of obstructive defecation syndrome. J Am Coll Surg2007;204:56. CrossRef

278. BoccasantaP, VenturiM, SalaminaG, et al.New trends in the surgical treatment of outlet obstruction: clinical and functional results of two novel transanal stapled techniques from a randomised controlled trial. Int J Colorectal Dis2004;19:359. CrossRef

279. DinningPG, FuentealbaSE, KennedyML, et al.Sacral nerve stimulation induces pan‐colonic propagating pressure waves and increases defecation frequency in patients with slow‐transit constipation. Colorectal Dis2007;9:123. CrossRef

280. HolzerB, RosenHR, NoviG, et al.Sacral nerve stimulation for neurogenic faecal incontinence. Br J Surg2007;94:749. CrossRef

281. MaloufAJ, WieselPH, NichollsT, et al.Short‐term effects of sacral nerve stimulation for idiopathic slow transit constipation. World J Surg2002;26:166. CrossRef

282. KammMA, DuddingTC. Sacral nerve stimulation for constipation: an international multi‐center study. Gastroenterology2007;132(Suppl. 2):198.

283. SwensonO. A new surgical treatment for Hirschsprung's disease. Surgery1950;28:371.

284. BoleySJ. An endorectal pull‐through operation with primary anastomosis for Hirchsprung's disease. Surg Gynecol Obstet1968;127:353.

285. NixonHH. Hirschsprung's disease: progress in management and diagnostics. World J Surg1985;9:189. CrossRef

286. PoissonJ, DevroedeG. Severe chronic constipation as a surgical problem. Surg Clin North Am1983;63:193.

287. ReadNW, AbouzekryL, ReadMG, et al.Anorectal function in elderly patients with fecal impaction. Gastroenterology1985;89:959.

288. IngeboKB, HeymanMB. Polyethylene glycol‐electrolyte solution for intestinal clearance in children with refractory encopresis. A safe and effective therapeutic program. Am J Dis Child1988;142:340. CrossRef

289. PuxtyJA, FoxRA. Golytely: a new approach to faecal impaction in old age. Age Ageing1986;15:182. CrossRef

290. LeungFW, RaoSS. Approach to fecal incontinence and constipation in older hospitalized patients. Hosp Pract2011;39:97. CrossRef

291. SinghG. Complications and comorbidities of constipation in adults. Gastroenterology2007;132(Suppl. 2):M2135.

292. XingJH, SofferEE. Adverse effects of laxatives. Dis Colon Rectum2001;44:1201. CrossRef